Squarepoint’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-687,151
| Closed | -$9.34M | – | 2840 |
|
|
2025
Q1 | $9.34M | Buy |
687,151
+638,532
| +1,313% | +$8.68M | 0.01% | 573 |
|
|
2024
Q4 | $991K | Buy |
48,619
+14,896
| +44% | +$304K | ﹤0.01% | 1542 |
|
|
2024
Q3 | $982K | Sell |
33,723
-89,957
| -73% | -$2.62M | ﹤0.01% | 1448 |
|
|
2024
Q2 | $2.87M | Buy |
123,680
+58,806
| +91% | +$1.37M | ﹤0.01% | 916 |
|
|
2024
Q1 | $1.33M | Buy |
64,874
+50,555
| +353% | +$1.04M | ﹤0.01% | 1202 |
|
|
2023
Q4 | $307K | Sell |
14,319
-95,750
| -87% | -$2.05M | ﹤0.01% | 1945 |
|
|
2023
Q3 | $2.27M | Buy |
+110,069
| New | +$2.27M | 0.01% | 905 |
|
|
2023
Q2 | – | Sell |
-235,662
| Closed | -$5.43M | – | 2484 |
|
|
2023
Q1 | $5.43M | Buy |
+235,662
| New | +$5.43M | 0.02% | 493 |
|
|
2022
Q4 | – | Sell |
-13,365
| Closed | -$410K | – | 2331 |
|
|
2022
Q3 | $410K | Buy |
+13,365
| New | +$410K | ﹤0.01% | 1476 |
|
|
2022
Q2 | – | Sell |
-34,435
| Closed | -$1.11M | – | 2232 |
|
|
2022
Q1 | $1.11M | Buy |
+34,435
| New | +$1.11M | ﹤0.01% | 1097 |
|
|
2021
Q4 | – | Sell |
-17,200
| Closed | -$868K | – | 2585 |
|
|
2021
Q3 | $868K | Sell |
17,200
-1,150
| -6% | -$58K | ﹤0.01% | 1136 |
|
|
2021
Q2 | $1.44M | Buy |
18,350
+13,022
| +244% | +$1.02M | 0.01% | 962 |
|
|
2021
Q1 | $304K | Buy |
+5,328
| New | +$304K | ﹤0.01% | 1864 |
|
|
2020
Q4 | – | Sell |
-14,411
| Closed | -$516K | – | 2598 |
|
|
2020
Q3 | $516K | Buy |
+14,411
| New | +$516K | 0.01% | 1324 |
|
|
2019
Q4 | – | Sell |
-18,657
| Closed | -$286K | – | 2437 |
|
|
2019
Q3 | $286K | Sell |
18,657
-12,279
| -40% | -$188K | ﹤0.01% | 1836 |
|
|
2019
Q2 | $642K | Sell |
30,936
-74,204
| -71% | -$1.54M | 0.01% | 1498 |
|
|
2019
Q1 | $2.44M | Buy |
+105,140
| New | +$2.44M | 0.03% | 693 |
|